Literature DB >> 11574678

Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs.

P Sazani1, S H Kang, M A Maier, C Wei, J Dillman, J Summerton, M Manoharan, R Kole.   

Abstract

The antisense activity of oligomers with 2'-O-methyl (2'-O-Me) phosphorothioate, 2'-O-methoxyethyl (2'-O-MOE) phosphorothioate, morpholino and peptide nucleic acid (PNA) backbones was investigated using a splicing assay in which the modified oligonucleotides blocked aberrant and restored correct splicing of modified enhanced green fluorescent protein (EGFP) precursor to mRNA (pre-mRNA), generating properly translated EGFP. In this approach, antisense activity of each oligomer was directly proportional to up-regulation of the EGFP reporter. This provided a positive, quantitative readout for sequence-specific antisense effects of the oligomers in the nuclei of individual cells. Nuclear localization of fluorescent labeled oligomers confirmed validity of the functional assay. The results showed that the free uptake and the antisense efficacy of neutral morpholino derivatives and cationic PNA were much higher than that of negatively charged 2'-O-Me and 2'-O-MOE congeners. The effects of the PNA oligomers were observed to be dependent on the number of L-lysine (Lys) residues at the C-terminus. The experiments suggest that the PNA containing Lys was taken up by a mechanism similar to that of cell-penetrating homeodomain proteins and that the Lys tail enhanced intracellular accumulation of PNA oligomer without affecting its ability to reach and hybridize to the target sequence.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11574678      PMCID: PMC60237          DOI: 10.1093/nar/29.19.3965

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  32 in total

Review 1.  Progress in antisense technology: the end of the beginning.

Authors:  S T Crooke
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

Review 2.  Protein transduction: unrestricted delivery into all cells?

Authors:  S R Schwarze; K A Hruska; S F Dowdy
Journal:  Trends Cell Biol       Date:  2000-07       Impact factor: 20.808

Review 3.  Morpholino antisense oligomers: the case for an RNase H-independent structural type.

Authors:  J Summerton
Journal:  Biochim Biophys Acta       Date:  1999-12-10

Review 4.  Cell-penetrating peptides.

Authors:  M Lindgren; M Hällbrink; A Prochiantz; U Langel
Journal:  Trends Pharmacol Sci       Date:  2000-03       Impact factor: 14.819

5.  Keeping the biotechnology of antisense in context.

Authors:  C A Stein
Journal:  Nat Biotechnol       Date:  1999-03       Impact factor: 54.908

Review 6.  2'-carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation.

Authors:  M Manoharan
Journal:  Biochim Biophys Acta       Date:  1999-12-10

7.  Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides.

Authors:  J K Taylor; Q Q Zhang; J R Wyatt; N M Dean
Journal:  Nat Biotechnol       Date:  1999-11       Impact factor: 54.908

Review 8.  Modification of alternative splicing pathways as a potential approach to chemotherapy.

Authors:  D Mercatante; R Kole
Journal:  Pharmacol Ther       Date:  2000-03       Impact factor: 12.310

9.  Deletion of individual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing.

Authors:  J G Karras; R A McKay; N M Dean; B P Monia
Journal:  Mol Pharmacol       Date:  2000-08       Impact factor: 4.436

10.  Inhibition of splicing of wild-type and mutated luciferase-adenovirus pre-mRNAs by antisense oligonucleotides.

Authors:  D Hodges; S T Crooke
Journal:  Mol Pharmacol       Date:  1995-11       Impact factor: 4.436

View more
  70 in total

1.  Temperature-dependent splicing of beta-globin pre-mRNA.

Authors:  Federica Gemignani; Peter Sazani; Paul Morcos; Ryszard Kole
Journal:  Nucleic Acids Res       Date:  2002-11-01       Impact factor: 16.971

2.  Infection by Mycoplasma hyorhinis strongly enhances uptake of antisense oligonucleotides: a reassessment of receptor-mediated endocytosis in the HepG2 cell line.

Authors:  Philippe de Diesbach; Francisca N'Kuli; Michel Delmée; Pierre J Courtoy
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

Review 3.  Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing.

Authors:  Peter Sazani; Ryszard Kole
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 4.  PNA Technology.

Authors:  Peter E Nielsen
Journal:  Mol Biotechnol       Date:  2004-03       Impact factor: 2.695

5.  Peptide nucleic acids conjugated to short basic peptides show improved pharmacokinetics and antisense activity in adipose tissue.

Authors:  Edward V Wancewicz; Martin A Maier; Andrew M Siwkowski; Klaus Albertshofer; Theodore M Winger; Andres Berdeja; Hans Gaus; Timothy A Vickers; C Frank Bennett; Brett P Monia; Richard H Griffey; Christopher J Nulf; Jiaxin Hu; David R Corey; Eric E Swayze; Garth A Kinberger
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

6.  Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria.

Authors:  Vincent Oustric; Hana Manceau; Sarah Ducamp; Rima Soaid; Zoubida Karim; Caroline Schmitt; Arienne Mirmiran; Katell Peoc'h; Bernard Grandchamp; Carole Beaumont; Said Lyoumi; François Moreau-Gaudry; Véronique Guyonnet-Dupérat; Hubert de Verneuil; Joëlle Marie; Herve Puy; Jean-Charles Deybach; Laurent Gouya
Journal:  Am J Hum Genet       Date:  2014-03-27       Impact factor: 11.025

7.  An apparent pseudo-exon acts both as an alternative exon that leads to nonsense-mediated decay and as a zero-length exon.

Authors:  Sushma-Nagaraja Grellscheid; Christopher W J Smith
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

Review 8.  Therapeutic potential of splice-switching oligonucleotides.

Authors:  John Bauman; Natee Jearawiriyapaisarn; Ryszard Kole
Journal:  Oligonucleotides       Date:  2009-03

Review 9.  Cell penetrating peptides: overview and applications to the delivery of oligonucleotides.

Authors:  F Said Hassane; A F Saleh; R Abes; M J Gait; Bernard Lebleu
Journal:  Cell Mol Life Sci       Date:  2009-11-07       Impact factor: 9.261

10.  Guanine analogues enhance antisense oligonucleotide-induced exon skipping in dystrophin gene in vitro and in vivo.

Authors:  Yihong Hu; Bo Wu; Allen Zillmer; Peijuan Lu; Ehsan Benrashid; Mingxing Wang; Timothy Doran; Mona Shaban; Xiaohua Wu; Qi Long Lu
Journal:  Mol Ther       Date:  2010-01-19       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.